Washed Microbiota Transplantation for Diabetic Gastroparesis
A legfontosabb adatok
- Ki végzi
- The Second Hospital of Nanjing Medical University
- Hol
- Nanjing (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 46 fő, tervezett
- Kezdés
- 2024. ápr. 1.
- Várható befejezés
- 2029. júl.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- washed microbiota transplantation
- placebo
- A regiszteradat frissítve
- 2026. augusztus 5.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with diabetes whose stomach empties too slowly (diabetic gastroparesis). It tests washed microbiota transplantation (gut bacteria from donors) against a placebo.
- Életkor
- Over 18 years, up to 100 Years.
- Nem
- Men and women. Women cannot be pregnant or breastfeeding.
- A betegség stádiuma
- Diabetes for over 1 year. Symptoms like bloating or feeling full early for at least 3 months, with a GCSI Total Score of 2.3 or more. A test in the past 3 months shows slow stomach emptying. A blockage in the upper gut was ruled out by imaging or endoscopy in the past 3 months.
- Korábbi kezelés
- People cannot join if they use medicines that affect gut movement, such as GLP-1 agonists. They cannot join if they took medicines that change gut bacteria in the last 48 hours. No stomach surgery in the past 1 year.
A részvétel fő kizáró okai
- Another stomach or nerve disease that may cause the slow stomach emptying
- Serious diabetes problems needing urgent care, such as diabetic ketoacidosis
- Serious heart problems (NYHA class III or more, heart attack or unstable angina within 6 months, long QTc)
- Moderate or severe liver disease (Child-Pugh B or C) or kidney disease stage 3b or above (GFR<45 ml/min/1.73m2)
- Active hepatitis, HIV, active tuberculosis, cancer, or drug or alcohol abuse
A regiszter feltételei, szó szerint
Mind a 24 feltétel megnézéseKevesebb
Ki vehet részt
- Subjects must meet all of the following inclusion criteria to enter the study:
- Diagnosed with diabetes for over 1 year
- Accompanied by symptoms such as abdominal bloating, early satiety, persisting for at least 3 months, with a GCSI Total Score greater than/equal to 2.3
- Objective evidence of delayed gastric emptying within the past 3 months, including but not limited to scintigraphic gastric emptying or gastric ultrasound
- Upper gastrointestinal obstructive lesions were ruled out by imaging or endoscopic examination within the past 3 months
- Males and nonpregnant, non-breastfeeding females who are aged more than 18 years and sign the informed consent form
- The subject or his/her legal representative gives informed consent, fully understands the purpose of the study, is able to communicate effectively with the investigator, and comprehends and complies with the requirements set forth in the study
Ki nem vehet részt
- Have any upper gastrointestinal pathology other than diabetic gastroparesis that would require therapy other than that provided in this trial
- Have a prior history of gastric surgery, including but not limited to gastric bypass, gastrectomy, gastric banding, pyloroplasty, fundoplication, or vagotomy in past 1 year
- Have been using medications affecting gastrointestinal motility, such as GLP-1 agonists
- Have any organic/neurological disease that is suspected to be causing gastroparesis, other than diabetes
- Have a history of medication that regulate intestinal microbiome in last 48 hours
- Have preexisting hepatic disease that meets Child-Pugh Class B (moderate; total score 7 to 9 points) or C (severe; total score 10 to 15 points)
- Have infectious diseases such as active hepatitis (requiring long-term use of drugs), HIV or active tuberculosis
- Have a history of drug abuse, alcoholism (defined as consuming more than 14 units per week, with 1 unit equivalent to 360 mL of beer, 45 mL of 40% alcohol, or 150 mL of wine), or substance misuse
- Other significant systemic illnesses, such as malignant tumors
- Have any of the following abnormalities in cardiac function and cardiac performance:; Cardiac function rating≥Ⅲ according to New York Heart Association (NYHA); New myocardial infarction or unstable angina pectoris within 6 months; Electrocardiogram indicated prolonged QTc interval (male QTc≥450ms, female QTc≥470ms); requiring drug intervention (more than Ⅱ atrioventricular block)
- Kidney disease with KDIGO stage 3b (GFR<45 ml/min/1.73m2) or above
- Subjects meeting any of the following exclusion criteria must be excluded from the study:
- Subjects who:
- Have contraindications for intestinal tubing
- Have serious diabetic complications need immediately be dealt, such as diabetic ketoacidosis
- Have poor lung function and those deemed by the investigator to be affected by the study treatment, such as during COPD exacerbations
- Have other situations in which the investigator deems it inappropriate to participate in this study
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 100 év között vagy?
Helyszínek itt: Kína
- Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical UniversityNanjing, KínaContact: Faming Zhang, PhDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
This is a randomized controlled trial to explore the efficacy and safety of washed microbiota transplantation (WMT) for diabetic gastroparesis (DGP) patients.
A vizsgálat 2 csoportja
- TreatmentA vizsgált kezelés
The patient will receive WMT once daily for a duration of 2 days
Kezelés: washed microbiota transplantation
- ControlPlacebo, összehasonlításként
The patient will receive a placebo of equal volume once daily for a duration of 2 days
Kezelés: placebo
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Efficacy and Safety of WMT in the Treatment of Diabetic Gastroparesis: A Multicenter, Randomized, Double-blind, Placebo-controlled Study
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT06340217: ki vehet részt
- A regiszteradat frissítve
- 2026. augusztus 5.